HSBC Holdings
KURA icon

HSBC Holdings’s Kura Oncology KURA Stock Holding History

HSBC Holdings’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.06M Buy
94,810
+5,778
+6% +$54.5K ﹤0.01% 1916
2026
Q1 		$736K Buy
89,032
+37,029
+71% +$318K ﹤0.01% 2027
2025
Q4 		$536K Sell
52,003
-79,189
-60% -$831K ﹤0.01% 2282
2025
Q3 		$1.15M Sell
131,192
-5,884
-4% -$41.9K ﹤0.01% 1737
2025
Q2 		$784K Buy
137,076
+82,585
+152% +$506K ﹤0.01% 1925
2025
Q1 		$351K Buy
54,491
+11,406
+26% +$88.9K ﹤0.01% 2280
2024
Q4 		$370K Buy
43,085
+26,922
+167% +$387K ﹤0.01% 2363
2024
Q3 		$316K Sell
16,163
-2,137
-12% -$43.3K ﹤0.01% 2304
2024
Q2 		$374K Buy
18,300
+2,167
+13% +$44.5K ﹤0.01% 2149
2024
Q1 		$344K Sell
16,133
-21,693
-57% -$422K ﹤0.01% 2341
2023
Q4 		$545K Buy
37,826
+4,589
+14% +$45.1K ﹤0.01% 2022
2023
Q3 		$300K Buy
+33,237
New +$337K ﹤0.01% 2217
2021
Q1 		– Sell
-6,147
Closed -$204K – 2951
2020
Q4 		$204K Buy
+6,147
New +$216K ﹤0.01% 2809

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

HSBC Holdings's KURA Position: Q2 2026 in Review

HSBC Holdings increased its Kura Oncology (KURA) stake by 6.5% in Q2 2026, buying an estimated $54.5K and bringing the position to 94,810 shares worth $1.06M. The position accounts for ﹤0.01% of the portfolio, ranked #1916.

HSBC Holdings first reported a position in KURA in Q4 2020 and has held it in 13 quarters since. The position peaked at $1.15M in Q3 2025. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • HSBC Holdings held 94,810 shares of Kura Oncology worth $1.06M as of Q2 2026.
  • HSBC Holdings bought 5,778 Kura Oncology shares in Q2 2026, an estimated $54.5K.
  • Kura Oncology made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #1916 holding.
  • HSBC Holdings first reported a position in Kura Oncology in Q4 2020 and has held it in 13 quarters since.
  • HSBC Holdings's Kura Oncology position peaked at $1.15M in Q3 2025.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.